Resection for hepatocellular carcinoma is a good option in Child‐Turcotte‐Pugh class A patients with cirrhosis who are eligible for liver transplantation

Carlos Margarit, Alfredo Escartín, Lluis Castells, Víctor Vargas, Elena Allende, Itxarone Bilbao – 23 September 2005 – The best treatment option for patients with single, early hepatocellular carcinoma (HCC) and cirrhosis, good liver function, and absence of portal hypertension remains to be established. The aim of this work was to compare the outcome of liver resection (LR) with that of liver transplantation (LT) for single, early HCC in Child‐Turcotte‐Pugh class A patients with cirrhosis younger than 70 years of age.

Living domino liver transplantation in an adult with congenital absence of portal vein

Takayuki Takeichi, Hideaki Okajima, Hiroko Suda, Shintarou Hayashida, Hironori Iwasaki, Manuel Zeledon Ramirez, Mikako Ueno, Katsuhiro Asonuma, Yukihiro Inomata – 23 September 2005 – Congenital absence of the portal vein (CAPV) is a rare malformation of the splanchnic venous system. Although CAPV is usually detected in the pediatric age group, our patient was a 35‐year‐old woman. She had been diagnosed with CAPV in 1996 when she was 27 years old. In 1998, she was placed on hemodialysis due to chronic renal failure.

Evaluation for liver transplantation: Adherence to AASLD referral guidelines in a large veterans affairs center

Venodhar R. Julapalli, Jennifer R. Kramer, Hashem B. El‐Serag – 23 September 2005 – Access of patients to liver transplantation involves three levels: referral for evaluation for transplantation, placement on a waiting list for transplantation, and receipt of a liver transplant. No study has formally evaluated access to liver transplantation at the referral level. Therefore, we sought to estimate the magnitude and determinants of consideration of liver transplantation in patients at a single, large Veterans Affairs medical center.

Gc‐globulin and prognosis in acute liver failure

Frank V. Schiødt, Lorenzo Rossaro, Richard T. Stravitz, A. Obaid Shakil, Raymond T. Chung, William M. Lee, Acute Liver Failure Study Group – 23 September 2005 – Serum concentrations of the actin scavenger Gc‐globulin are reduced in acute liver failure (ALF). Prospectively, we tested Gc‐globulin's value to predict outcome following ALF using sera from 182 patients with ALF from the U.S. ALF Study Group. Admission serum levels of Gc‐globulin (normal range: 350‐500 mg/L) were studied by an immunonephelometric method.

Recurrent primary biliary cirrhosis: Peritransplant factors and ursodeoxycholic acid treatment post‐liver transplant

Jennifer E. Guy, Peiqing Qian, Jeffrey A. Lowell, Marion G. Peters – 23 September 2005 – Primary biliary cirrhosis (PBC) recurs after orthotopic liver transplantation (OLT) in up to one‐third of patients. These patients are typically asymptomatic, can be identified by abnormal liver biochemistries, and have evidence of histologic recurrence on liver biopsy. The effect of treatment on recurrence has not been determined. This pilot study evaluates the factors associated with recurrent PBC and describes our experience using ursodeoxycholic acid treatment in this patient population.

Subscribe to